No juice: Prickly pear extract hangover cure encounters EU headache

By Shane STARLING

- Last updated on GMT

Opuntia ficus-indica's hangover-curing ability was not assessed by EFSA as it deemed the claim too general
Opuntia ficus-indica's hangover-curing ability was not assessed by EFSA as it deemed the claim too general
The EU’s chief science agency has turned down a hangover health claim for a prickly pear extract before even evaluating the science behind it because it said the claim was too vague.

Opuntia ficus-indica​ extracts could help in the, “rapid recovery of cellular activity post stress”​ proposed Maltese firm ICP Ltd but the European Food Safety Authority (EFSA) said the article 13.5 claim was ‘non-specific’ and threw it out without passing comment on the dossier’s contents.

Institute of Cellular Pharmacology (ICP) was not available for comment but UK-based EU food law expert Owen Warnock said article 10.3 of the nutrition and health claims regulation (NHCR) was clear about non-specific claims.

“What’s more in practical operation of the NHCR, EFSA can only assess the scientific validity of a claim if it is specific enough to be defined and assessed,”​ Warnock told us.

“A claim also need to be specific enough for a consumer to understand it since article 5 says a claim may be used only if an average consumer can understand the claim.”

Warnock said, ‘rapid recovery of cellular activity post stress’, “did not indicate clearly any particular aspect of cellular activity.”

“The case illustrates the need for applicants to be precise about the nature of the beneficial effect being claimed if they are to win approval.  This application looks, from the EFSA opinion, not to have been well-prepared or thorough – but the applicant may well have been hampered by what appears to be a fairly thin scientific evidence base.”

The NDA opinion can be found here​.

Related news

Show more

Related products

show more

Research for Restorative Sleep: Levagen®+

Research for Restorative Sleep: Levagen®+

Content provided by Gencor | 27-Sep-2024 | White Paper

Levagen®+ is Gencor's branded Palmitoylethanolamide (PEA), an endogenous fatty acid amide naturally found in every cell of the body.

Research for Restorative Sleep: Levagen®+

Research for Restorative Sleep: Levagen®+

Content provided by Gencor | 09-Sep-2024 | White Paper

Levagen®+ is Gencor's branded Palmitoylethanolamide (PEA), an endogenous fatty acid amide naturally found in every cell of the body.

Research to Reality: Restorative Sleep

Research to Reality: Restorative Sleep

Content provided by Gencor | 02-Sep-2024 | White Paper

Gencor prides itself on its cutting-edge, science-driven solutions. Explore sleep support through gold-standard, clinically-validated dietary supplement...

Go Beyond Ordinary in Cognitive Health - BacoMind™

Go Beyond Ordinary in Cognitive Health - BacoMind™

Content provided by Natural Remedies Pvt. Ltd. | 26-Jun-2024 | White Paper

BacoMind™, this groundbreaking, clinically proven, and pioneering Bacopa monnieri extract unleashes the power of 9 bioactive compounds to organically boost...

Related suppliers

Follow us

Products

View more

Webinars